CBT is an evidence-supported treatment for adult ADHD. Evolving trends in CBT have already improved adult ADHD treatment, and some hold the promise of further gains.

The FDA has cleared LumosityRx to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type ADHD.

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

A new online tool is designed to help families and clinicians make informed treatment decisions. The most extensive assessment so far of available ADHD treatments reports that medication for both ...

Difficulty many drug treatment service users face in accessing mental healthcare described as ‘torture by bureaucracy’ as ...

Stimulants act fast, and nonstimulants offer steadier effects. So what are the best ADHD medications for adults? Experts explain the options.

A study has identified the most effective attention deficit hyperactivity disorder (ADHD) treatments. The largest of its kind to date, it found that medication is the most effective treatment for both ...

Drugmaker GSK said on Tuesday that Exdensur (depemokimab), an ultra-long-acting biologic to treat respiratory diseases, has ...

There is no scientific evidence base for routine use of multiple psychiatric drugs, particularly for children.

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and ...

Last month, Southern Weekly reported on a policy at some hospitals in Shanxi requiring that ADHD patients get a "Class 1 ...

In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...